Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient.

WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...

With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...

Actor Dave Coulier, known for playing Uncle Joey on the TV series Full House, announced he has stage 3 non-Hodgkin's lymphoma ...

Understanding what to patent versus what to keep as a trade secret is an increasingly important and challenging decision ...

Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.